Match tier
Listed
Presence
Current · Arkansas
Last published
2026
Sources
OpenAlex · ORCID
Refreshed
2026-10-06
R
Research Areas
Biomedical Subjects
Links
Biography and Research Information
OverviewAI-generated summary
Robert Smith's research has explored various aspects of human health and disease, with a focus on infectious diseases, maternal health, and genotoxicity assessment. His work includes studies on malaria vaccine development, investigating the production and efficacy of protein-based vaccines like RH5.1. Smith has also examined infectious complications during pregnancy, including HIV-1 vertical transmission and Hepatitis C virus prevalence in pregnant women. His research extends to genotoxicity, with publications addressing the reduction of false positives in mammalian cell assays by accurately measuring toxicity. Smith has collaborated with several researchers at the University of Arkansas for Medical Sciences, including Fenghuang Zhan, Guido Tricot, John D. Shaughnessy, and Eric R. Siegel. His scholarly contributions are reflected in an h-index of 19 and over 1,300 citations across approximately 50 publications.
Metrics
- h-index: 19
- Publications: 50
- Citations: 1,390
Selected Publications
-
Long-Term Follow-Up of Patients With Multiple Myeloma Treated on Earlier Total Therapy Protocols (2025)
-
Long-term follow-up of Total Therapy IV: a phase 3 clinical trial for standard-risk multiple myeloma (2024)
Collaboration Network
Top Collaborators
Samer Al Hadidi
University of Arkansas for Medical Sciences
2 shared publications
In database
- Long-term follow-up of Total Therapy IV: a phase 3 clinical trial for standard-risk multiple myeloma
- Long-Term Follow-Up of Patients With Multiple Myeloma Treated on Earlier Total Therapy Protocols
Obada Ababneh
The University of Texas MD Anderson Cancer Center (US)
2 shared publications
- Long-term follow-up of Total Therapy IV: a phase 3 clinical trial for standard-risk multiple myeloma
- Long-Term Follow-Up of Patients With Multiple Myeloma Treated on Earlier Total Therapy Protocols
Carolina Schinke
University of Arkansas for Medical Sciences
2 shared publications
In database
- Long-term follow-up of Total Therapy IV: a phase 3 clinical trial for standard-risk multiple myeloma
- Long-Term Follow-Up of Patients With Multiple Myeloma Treated on Earlier Total Therapy Protocols
Sharmilan Thanendrarajan
University of Arkansas for Medical Sciences
2 shared publications
In database
- Long-term follow-up of Total Therapy IV: a phase 3 clinical trial for standard-risk multiple myeloma
- Long-Term Follow-Up of Patients With Multiple Myeloma Treated on Earlier Total Therapy Protocols
Clyde Bailey
University of Arkansas for Medical Sciences
2 shared publications
In database
- Long-term follow-up of Total Therapy IV: a phase 3 clinical trial for standard-risk multiple myeloma
- Long-Term Follow-Up of Patients With Multiple Myeloma Treated on Earlier Total Therapy Protocols
Susan Panozzo
University of Arkansas for Medical Sciences
2 shared publications
In database
- Long-term follow-up of Total Therapy IV: a phase 3 clinical trial for standard-risk multiple myeloma
- Long-Term Follow-Up of Patients With Multiple Myeloma Treated on Earlier Total Therapy Protocols
Guido Tricot
University of Arkansas for Medical Sciences
2 shared publications
In database
- Long-term follow-up of Total Therapy IV: a phase 3 clinical trial for standard-risk multiple myeloma
- Long-Term Follow-Up of Patients With Multiple Myeloma Treated on Earlier Total Therapy Protocols
John D. Shaughnessy
University of Arkansas for Medical Sciences
2 shared publications
In database
- Long-term follow-up of Total Therapy IV: a phase 3 clinical trial for standard-risk multiple myeloma
- Long-Term Follow-Up of Patients With Multiple Myeloma Treated on Earlier Total Therapy Protocols
Fenghuang Zhan
University of Arkansas for Medical Sciences
2 shared publications
In database
- Long-term follow-up of Total Therapy IV: a phase 3 clinical trial for standard-risk multiple myeloma
- Long-Term Follow-Up of Patients With Multiple Myeloma Treated on Earlier Total Therapy Protocols
Jeffrey R. Sawyer
University of Arkansas for Medical Sciences (US)
2 shared publications
- Long-term follow-up of Total Therapy IV: a phase 3 clinical trial for standard-risk multiple myeloma
- Long-Term Follow-Up of Patients With Multiple Myeloma Treated on Earlier Total Therapy Protocols
Eric R. Siegel
University of Arkansas for Medical Sciences
2 shared publications
In database
- Long-term follow-up of Total Therapy IV: a phase 3 clinical trial for standard-risk multiple myeloma
- Long-Term Follow-Up of Patients With Multiple Myeloma Treated on Earlier Total Therapy Protocols
Frits van Rhee
University of Arkansas for Medical Sciences
2 shared publications
In database
- Long-term follow-up of Total Therapy IV: a phase 3 clinical trial for standard-risk multiple myeloma
- Long-Term Follow-Up of Patients With Multiple Myeloma Treated on Earlier Total Therapy Protocols
Maurizio Zangari
University of Arkansas for Medical Sciences
2 shared publications
In database
- Long-term follow-up of Total Therapy IV: a phase 3 clinical trial for standard-risk multiple myeloma
- Long-Term Follow-Up of Patients With Multiple Myeloma Treated on Earlier Total Therapy Protocols
Daisy Alapat
University of Arkansas Medical Center
1 shared publication
In database
- Long-term follow-up of Total Therapy IV: a phase 3 clinical trial for standard-risk multiple myeloma
Bart Barlogie
University of Arkansas for Medical Sciences
1 shared publication
In database
- Long-term follow-up of Total Therapy IV: a phase 3 clinical trial for standard-risk multiple myeloma
Similar Researchers
Based on overlapping research topics
Jeffrey Adams
University of Arkansas for Medical Sciences
Microbial infections and disease research
Pharmacological Effects and Toxicity Studies
Health Sciences Research and Education
Yazan A. Bashtawi
University of Arkansas for Medical Sciences
Microbial infections and disease research
Host-Pathogen Interactions
Pharmacological Effects and Toxicity Studies
Dipok Kumer Shill
University of Arkansas for Medical Sciences
Microbial infections and disease research
Host-Pathogen Interactions
Pharmacological Effects and Toxicity Studies
Cherin C. Pace
University of Arkansas for Medical Sciences
Microbial infections and disease research
Host-Pathogen Interactions
Pharmacological Effects and Toxicity Studies
John P. Shock
University of Arkansas for Medical Sciences
Microbial infections and disease research
Host-Pathogen Interactions
Viral Infections and Vectors
Monica Sadaka
University of Arkansas at Little Rock
Microbial infections and disease research
Host-Pathogen Interactions
Pharmacological Effects and Toxicity Studies